Written by: Immunization Action Coalition The recommended dosing intervals for the 2-dose mRNA COVID-19 vaccines are 21 days for Pfizer-BioNTech’s vaccine and 28 days for Moderna’s. Some vaccination clinics are scheduling dose #2 appointments up to 4 days early (i.e., at 17 days) for Pfizer-BioNTech’s vaccine, and as early as 24 days for Moderna’s. COVID-19 […]

Read More ›

Emphasizing the role that pharmacists and state boards of pharmacy play in protecting the public health, NABP has sent a letter to congressional leadership urging Congress to continue supporting robust investments in federal programs to combat both the ongoing opioid epidemic and coronavirus disease 2019 (COVID-19) pandemic. Signed by NABP Executive Director/Secretary Lemrey “Al” Carter, […]

Read More ›

HHS Advisory Opinion States That Pharmacies May Order and Administer COVID-19 Tests in All States As the number of coronavirus disease 2019 (COVID-19) fatalities in the United States climbs beyond 100,000, the US Department of Health and Human Services’ (HHS) Office of the General Counsel (OGC) has issued an advisory opinion that says licensed pharmacists […]

Read More ›

Written by: Matthew Rubin, Faegre Drinker Consulting Now more than two months into the United States’ public health emergency for the coronavirus disease 2019 (COVID-19) pandemic, consumer behavior and related commerce have changed drastically. Stay-in-place orders, social distancing practices, and self-imposed quarantines have left hundreds of millions of Americans – and billions more globally – […]

Read More ›

Illegal Online Pharmacies Exploit Vulnerable Consumers During the COVID-19 Pandemic NABP released the May 2020 Rogue Rx Activity Report, Rogue Online Pharmacies in the Time of Pandemic: Capitalizing on Misinformation and Fear. The report highlights how illegal online pharmacies use the coronavirus disease 2019 (COVID-19) to expand operations and prey on consumer fears. A summary of […]

Read More ›

FDA Updates Guidance Documents on Compounding For Hospitalized Patients During the COVID-19 Pandemic Food and Drug Administration (FDA) has updated two guidance documents regarding temporary policies for compounding of hospitalized patients during the coronavirus disease 2019 (COVID-19) pandemic. The updated guidance documents include: Temporary Policy for Compounding of Certain Drugs for Hospitalized Patients by Outsourcing […]

Read More ›

The National Association of Boards of Pharmacy® (NABP®) released the May 2020 Rogue Rx Activity Report, Rogue Online Pharmacies in the Time of Pandemic: Capitalizing on Misinformation and Fear. The report highlights how illegal online pharmacies use coronavirus disease 2019 (COVID-19) to expand operations and prey on consumer fears. NABP has identified dozens of rogue online pharmacies […]

Read More ›

NABP Announces Accreditation Program for Home Infusion Therapy Pharmacy NABP is pleased to announce the addition of Home Infusion Therapy Pharmacy Accreditation. The addition of a Home Infusion Therapy Pharmacy Accreditation to the Association’s already robust offerings enables NABP to provide customers with the most comprehensive set of pharmacy accreditation options of any organization. Read […]

Read More ›

FDA Clarifies Compounding Rules, Offers Flexibility to Help Ease Drug Shortages During COVID-19 Pandemic The Food and Drug Administration (FDA) noted it will use discretion in enforcing certain standards related to 503A and 503B compounding in an effort to ease drug shortages during the coronavirus disease 2019 (COVID-19) pandemic. During an April 30, 2020 American […]

Read More ›

HHS Expands Telehealth Access In Response to COVID-19 In an effort to prevent and respond to the coronavirus disease 2019 (COVID-19) pandemic, the United States Department of Health and Human Services (HHS) has awarded $20 million to increase telehealth access and infrastructure for health care providers and families. The funds, which are awarded through the […]

Read More ›